Pelthos Therapeutics, Inc. (PTHS)
22.99
-0.95
(-3.97%)
USD |
NYAM |
Dec 12, 16:00
22.72
-0.27
(-1.17%)
After-Hours: 20:00
Pelthos Therapeutics Total Assets (Quarterly): 126.43M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 1.477B |
| Agenus, Inc. | 233.89M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| Travere Therapeutics, Inc. | 538.58M |
| Genprex, Inc. | 3.562M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.18M |
| Shareholders Equity (Quarterly) | 58.25M |
| Debt to Equity Ratio | 0.0597 |
| Current Ratio | 1.980 |
| Net Debt Paydown Yield | -3.77% |